| Original language | English (Ireland) |
|---|---|
| Media of output | Other Item |
| Volume | 39 |
| Publication status | Published - 1 Oct 2016 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
International, randomized phase 3 study results: Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM))
- Michael O'Dwyer
Research output: Other contribution (Published) › Other contribution